Evidence map›Paper›PMID 35894928›Full record

ArticleThe journal of physical chemistry. A2022

Chalcogen Effects in the Photophysical Properties of Dimethylamino-1,8-naphthalimide Dyes Revealed by DFT Investigation.

Marta Erminia Alberto, Bruna Clara De Simone, Tiziana Marino, Marirosa Toscano, Nino Russo

Open access · hybridAbstract read
In one paragraph

Article in The journal of physical chemistry. A, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marta Erminia AlbertoDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, 87036 Rende (CS), Italy.ORCID 0000-0001-9925-7233
Bruna Clara De SimoneDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, 87036 Rende (CS), Italy.
Tiziana MarinoDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, 87036 Rende (CS), Italy.
Marirosa ToscanoDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, 87036 Rende (CS), Italy.
Nino RussoDipartimento di Chimica e Tecnologie Chimiche, Università della Calabria, 87036 Rende (CS), Italy.ORCID 0000-0003-3826-3386
University of Calabria · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thionation of carbonyl groups of known dyes is a rapidly emerging strategy to propose an advance toward heavy-atom-free photosensitizers to be used in photodynamic therapy (PDT). The sulfur-for-oxygen replacement has recently proved to enhance the singlet oxygen quantum yield of some existing fluorophores and to shift the absorption band at longer wavelengths. Drawing inspiration from this challenging evidence, the effect of both sulfur- and selenium-for-oxygen replacement in the skeleton of the oxo-4-dimethylamino-1,8-naphthalimide molecule (DMN) has been analyzed by means of a DFT study. The thio- and seleno-derivatives (SDMN and SeDMN, respectively) have been shown to offer the possibility to access a multitude of ISC (intersystem crossing) pathways involved in the triplet deactivation mechanisms with a consequent enhancement of the singlet oxygen production, also arising from the change of orbital type involved in the radiationless

Indexed as

SeleniumSinglet OxygenFluorescent DyesNaphthalimidesOxygenPhotosensitizing AgentsQuantum TheorySulfurFluorescent DyesNaphthalimidesOxygenPhotosensitizing AgentsSeleniumSinglet OxygenSulfur

Identifiers

PMID35894928
PMCPMC9376948
OpenAlexW4288051202

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.